Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
4,700,385
-
Share change
-
-119,471
-
Total reported value
-
$728,635,260
-
Put/Call ratio
-
17%
-
Price per share
-
$155.03
-
Number of holders
-
241
-
Value change
-
-$18,428,171
-
Number of buys
-
75
-
Number of sells
-
109
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q1 2023
As of 31 Mar 2023,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
241 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,700,385 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, Raymond James Financial Services Advisors, Inc., Royal Bank of Canada, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, Berger Financial Group, Inc, and ADVISOR GROUP HOLDINGS, INC..
This page lists
241
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.